Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer – News-Medical.net
News-Medical.net |
Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer
News-Medical.net Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers … |
